Transcriptomics in cancer revealed by Positron Emission Tomography radiomics.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 03 2020
Historique:
received: 09 07 2019
accepted: 13 03 2020
entrez: 30 3 2020
pubmed: 30 3 2020
medline: 1 12 2020
Statut: epublish

Résumé

Metabolic images from Positron Emission Tomography (PET) are used routinely for diagnosis, follow-up or treatment planning purposes of cancer patients. In this study we aimed at determining if radiomic features extracted from

Identifiants

pubmed: 32221360
doi: 10.1038/s41598-020-62414-z
pii: 10.1038/s41598-020-62414-z
pmc: PMC7101432
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5660

Références

IEEE Trans Radiat Plasma Med Sci. 2019 Mar;3(2):162-169
pubmed: 34722958
J Nucl Med. 2011 Mar;52(3):369-78
pubmed: 21321270
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):630-641
pubmed: 29177871
Acta Oncol. 2010 Oct;49(7):1012-6
pubmed: 20831489
J Nucl Med. 2015 Jan;56(1):38-44
pubmed: 25500829
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Acad Radiol. 2014 Feb;21(2):232-49
pubmed: 24439337
IEEE Trans Radiat Plasma Med Sci. 2020 Jan;4(1):37-49
pubmed: 32939423
Pattern Recognit. 2009 Jun 1;42(6):1162-1171
pubmed: 20161266
J Nucl Med. 2012 May;53(5):693-700
pubmed: 22454484
J Nucl Med. 2010 Sep;51(9):1368-76
pubmed: 20720054
Cancer Cell. 2004 May;5(5):489-500
pubmed: 15144956
Sci Rep. 2015 Jun 05;5:11044
pubmed: 26251068
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D428-32
pubmed: 15608231
Med Image Anal. 2018 Feb;44:177-195
pubmed: 29268169
J Med Imaging (Bellingham). 2015 Oct;2(4):041002
pubmed: 26251842
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1046-1055
pubmed: 31811344
Sci Rep. 2019 Jul 5;9(1):9743
pubmed: 31278324
IEEE Trans Med Imaging. 2009 Jun;28(6):881-93
pubmed: 19150782
J Nucl Med. 2009 May;50 Suppl 1:31S-42S
pubmed: 19380411
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nat Genet. 2003 Jun;34(2):166-76
pubmed: 12740579
Nat Rev Cancer. 2011 Jan;11(1):9-22
pubmed: 21160525
Acta Oncol. 2013 Oct;52(7):1391-7
pubmed: 24047337
Br J Radiol. 2006 Sep;79 Spec No 1:S27-35
pubmed: 16980683
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):151-165
pubmed: 27271051
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
PLoS One. 2014 Jul 15;9(7):e102107
pubmed: 25025374
Med Phys. 2013 Aug;40(8):082503
pubmed: 23927348
Lancet Oncol. 2018 Sep;19(9):1180-1191
pubmed: 30120041
Sci Rep. 2017 Aug 31;7(1):10117
pubmed: 28860628
EBioMedicine. 2019 Jul;45:70-80
pubmed: 31255659
Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1449-58
pubmed: 21461734
PLoS One. 2014 Feb 06;9(2):e87761
pubmed: 24516561
Clin Radiol. 2010 Jul;65(7):517-21
pubmed: 20541651
Eur Radiol. 2014 Sep;24(9):2077-87
pubmed: 24965509
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1662-71
pubmed: 23857457
Phys Med Biol. 2013 Jan 21;58(2):187-203
pubmed: 23257054
Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1008-15
pubmed: 19352191
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):78-84
pubmed: 12483413
Acta Oncol. 2017 Nov;56(11):1531-1536
pubmed: 28820287
J Nucl Med. 2017 Mar;58(3):406-411
pubmed: 27765856
Eur Radiol. 2020 Jan;30(1):547-557
pubmed: 31396730
Nat Biotechnol. 2007 Jun;25(6):675-80
pubmed: 17515910
NPJ Breast Cancer. 2018 Aug 16;4:24
pubmed: 30131973
Recent Results Cancer Res. 2013;187:351-69
pubmed: 23179888
Head Neck. 2009 Feb;31(2):195-201
pubmed: 19107945
Med Phys. 2015 Dec;42(12):6784-97
pubmed: 26632036
J Nucl Med. 2017 Apr;58(4):569-576
pubmed: 27688480

Auteurs

Florent Tixier (F)

Department of Nuclear Medicine, Poitiers University Hospital, Poitiers, France. florent.tixier@gmail.com.
LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France. florent.tixier@gmail.com.

Catherine Cheze-le-Rest (C)

Department of Nuclear Medicine, Poitiers University Hospital, Poitiers, France.
LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Ulrike Schick (U)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Radiation Oncology Department, University Hospital, Brest, France.

Brigitte Simon (B)

INSERM, UMR 1078, Université de Brest, Génétique Génomique Fonctionnelle et Biotechnologies, Etablissement Français du Sang, Brest, France.

Xavier Dufour (X)

Head and Neck Department, Poitiers University Hospital, Poitiers, France.

Stéphane Key (S)

Radiation Oncology Department, University Hospital, Brest, France.

Olivier Pradier (O)

Radiation Oncology Department, University Hospital, Brest, France.

Marc Aubry (M)

CNRS, UMR 6290, IGDR, Université de Rennes 1, Rennes, France.

Mathieu Hatt (M)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Laurent Corcos (L)

INSERM, UMR 1078, Université de Brest, Génétique Génomique Fonctionnelle et Biotechnologies, Etablissement Français du Sang, Brest, France.

Dimitris Visvikis (D)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH